The Biomedical & Life Sciences Collection hosts a series of live immunology webinars.
Registration for upcoming events is free and recordings of all past events are available.View All
Dr. Vorstman’s initial research focused on the psychiatric and genetic aspects of the 22q11.2 deletion. After obtaining his PhD in 2008, he broadened the scope from 22q11DS to the study of genotype-phenotype relations in neurodevelopmental disorders, in particular autism, intellectual disability and schizophrenia. His ambition is to further insights into... read morethe genetic architecture underlying these disorders as well as to improve methods to measure the associated phenotypes. He developed, with Professor Kas at the University of Groningen in the Netherlands, BEHAPP, a smartphone application for the measurement of social and communicative behaviors, which is currently implemented in several studies generating the first data of this kind. Dr. Vorstman is also the director of the Autism Research Unit at the Hospital for Sick Children; together with his team he initiated a multidisciplinary clinic called DAGSY (Developmental Assessment of Genetically Susceptible Youth), designated for children with genetic risk variants associated with a psychiatric or neurodevelopmental outcomes. His work is funded by several grants, including from the CIHR and NIMH.